scholarly journals Effect of a fat spread enriched with medium-chain triacylglycerols and a special fatty acid-micronutrient combination on cardiometabolic risk factors in overweight patients with diabetes

2011 ◽  
Vol 8 (1) ◽  
pp. 21 ◽  
Author(s):  
Roswitha Siener ◽  
Christina Ehrhardt ◽  
Norman Bitterlich ◽  
Christine Metzner
Keyword(s):  
Risk Factors ◽  
Fatty Acid ◽  
Cardiometabolic Risk ◽  
Cardiometabolic Risk Factors ◽  
Medium Chain ◽  
Patients With Diabetes

scholarly journals Omega-3 polyunsaturated fatty acid profiles and relationship with cardiometabolic risk factors in Cree (Eeyouch) of Northern Québec

2016 ◽  
Vol 75 (1) ◽  
pp. 30361 ◽  
Author(s):  
Françoise Proust ◽  
Olivia Drescher ◽  
Elhadji A. Laouan-Sidi ◽  
Elizabeth Robinson ◽  
Michel Lucas ◽  
...  
Keyword(s):  
Risk Factors ◽  
Fatty Acid ◽  
Polyunsaturated Fatty Acid ◽  
Cardiometabolic Risk ◽  
Cardiometabolic Risk Factors ◽  
Fatty Acid Profiles ◽  
Omega 3

scholarly journals Effect of a Family-Based Intervention on Nutrient Biomarkers, Desaturase Enzyme Activities, and Cardiometabolic Risk Factors in Children with Overweight and Obesity

2019 ◽  
Vol 4 (1) ◽  
Author(s):  
Nirupa R Matthan ◽  
Judith Wylie-Rosett ◽  
Xiaonan Xue ◽  
Qi Gao ◽  
Adriana E Groisman-Perelstein ◽  
...  
Keyword(s):  
Risk Factors ◽  
Fatty Acid ◽  
Glucose Metabolism ◽  
Lipid Profile ◽  
Cardiometabolic Risk ◽  
Liver Enzymes ◽  
Overweight And Obesity ◽  
Cardiometabolic Risk Factors ◽  
Family Based ◽  
The Impact

ABSTRACT Background Developing dietary strategies to prevent excess weight gain during childhood is critical to stem the current obesity epidemic and associated adverse cardiometabolic consequences. Objectives We aimed to assess how participation in a family-based weight-management intervention affected nutrient biomarkers and cardiometabolic risk factors (CMRFs) in children (7–12 y old; n = 321) with baseline BMI z score (BMIz) ≥85th percentile. Methods This was a secondary analysis from a randomized-controlled, parallel-arm clinical trial. Families of children, recruited from a largely Hispanic population, were assigned to Standard Care (SC; American Academy of Pediatrics overweight/obesity recommendations), or SC + Enhanced Program (SC + EP; 8 skill-building cores, monthly support sessions, targeted diet/physical activity strategies). Nutrient biomarkers (plasma carotenoids, fat-soluble vitamins, RBC fatty acid profiles, desaturase indexes) and CMRFs were measured in archived blood samples collected at baseline and the end of the 1-y intervention. Results Children in both groups had significantly lower trans fatty acid and higher pentadecylic acid (15:0), PUFA n–3, and β-carotene concentrations, indicative of decreased hydrogenated fat and increased dairy, vegetable oil, fish, and fruit/vegetable intake, respectively. Similar changes were seen in de novo lipogenesis and desaturase indexes, as well as CMRFs (BMIz, lipid profile, inflammation, adipokines, liver enzymes) in both groups. Using multiple logistic regression, increase in carotenoids and decrease in endogenously synthesized SFA, MUFA, PUFA n–6, and desaturase indexes were associated with improvements in BMIz, blood pressure, lipid profile, glucose metabolism, inflammatory biomarkers, adipokines, and liver enzymes. Trans fatty acids were associated with improvements in BMIz, glucose metabolism, and leptin, with less favorable effects on inflammatory markers and adiponectin. Conclusions Providing targeted family-based behavioral counseling, as part of SC, can help overweight/obese children adopt healthier eating patterns that are associated with modest improvements in BMIz and several CMRFs. Limited additional benefit was observed with SC + EP. These results provide critical data to design subsequent interventions to increase the impact of family-based obesity prevention programs. This trial was registered at clinicaltrials.gov as NCT00851201.

scholarly journals Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Ernesto Maddaloni ◽  
◽  
Luca D’Onofrio ◽  
Francesco Alessandri ◽  
Carmen Mignogna ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiometabolic Risk ◽  
Adverse Outcomes ◽  
Cardiometabolic Risk Factors ◽  
Chronic Obstructive ◽  
Composite Outcome ◽  
Increased Risk ◽  
Cardiometabolic Disorders ◽  
Patients With Diabetes ◽  
Primary Composite Outcome

Abstract Background Cardiometabolic disorders may worsen Covid-19 outcomes. We investigated features and Covid-19 outcomes for patients with or without diabetes, and with or without cardiometabolic multimorbidity. Methods We collected and compared data retrospectively from patients hospitalized for Covid-19 with and without diabetes, and with and without cardiometabolic multimorbidity (defined as ≥ two of three risk factors of diabetes, hypertension or dyslipidaemia). Multivariate logistic regression was used to assess the risk of the primary composite outcome (any of mechanical ventilation, admission to an intensive care unit [ICU] or death) in patients with diabetes and in those with cardiometabolic multimorbidity, adjusting for confounders. Results Of 354 patients enrolled, those with diabetes (n = 81), compared with those without diabetes (n = 273), had characteristics associated with the primary composite outcome that included older age, higher prevalence of hypertension and chronic obstructive pulmonary disease (COPD), higher levels of inflammatory markers and a lower PaO2/FIO2 ratio. The risk of the primary composite outcome in the 277 patients who completed the study as of May 15th, 2020, was higher in those with diabetes (Adjusted Odds Ratio (adjOR) 2.04, 95%CI 1.12–3.73, p = 0.020), hypertension (adjOR 2.31, 95%CI: 1.37–3.92, p = 0.002) and COPD (adjOR 2.67, 95%CI 1.23–5.80, p = 0.013). Patients with cardiometabolic multimorbidity were at higher risk compared to patients with no cardiometabolic conditions (adjOR 3.19 95%CI 1.61–6.34, p = 0.001). The risk for patients with a single cardiometabolic risk factor did not differ with that for patients with no cardiometabolic risk factors (adjOR 1.66, 0.90–3.06, adjp = 0.10). Conclusions Patients with diabetes hospitalized for Covid-19 present with high-risk features. They are at increased risk of adverse outcomes, likely because diabetes clusters with other cardiometabolic conditions.

Cardiometabolic Risk Factors at 5 Years After Omega-3 Fatty Acid Supplementation in Infancy

PEDIATRICS ◽  
2018 ◽  
Vol 142 (1) ◽  
pp. e20162623 ◽  
Author(s):  
Valene H.L. See ◽  
Trevor A. Mori ◽  
Susan L. Prescott ◽  
Lawrence J. Beilin ◽  
Sally Burrows ◽  
...  
Keyword(s):  
Risk Factors ◽  
Fatty Acid ◽  
Cardiometabolic Risk ◽  
Cardiometabolic Risk Factors ◽  
Omega 3 ◽  
Fatty Acid Supplementation ◽  
Acid Supplementation ◽  
Omega 3 Fatty Acid
Sign in / Sign up

Export Citation Format

Share Document